TRAIP has carcinogenic properties, and it is negatively correlated with the prognosis of patients with liver cancer and lung cancer, suggesting that TRAIP may be a promising therapeutic target for those types of cancer [42, 43]. This evidence concerns the gene TRAIP and liver cancer.